ConductScience.org, home

Paper3924285

Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.

Bayliss J and 5 others. Br Med J (Clin Res Ed), 1985. Cited by 88 papers, by iCite.

Cite this record

ConductScience Library. Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin. Papers, record 3924285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3924285

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.
PubMed
Journal
Br Med J (Clin Res Ed)
PubMed
Year
1985
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
2.52
iCite
Revised in PubMed
2019-05-01
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bayliss JJ
2Norell MSM S
3Canepa-Anson RR
4Reid CC
5Poole-Wilson PP
6Sutton GG

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CaptoprilMajor topic
Coronary DiseaseMajor topic
PrazosinMajor topic
ProlineMajor topic
QuinazolinesMajor topic
Renin-Angiotensin SystemMajor topic
Aged
Chronic Disease
Clinical Trials as Topic
Double-Blind Method
Female
Hemodynamics
Humans
Male
Middle Aged
Norepinephrine
Time Factors

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15452310Renin relationships in congestive cardiac failure, treated and untreated.Am Heart J1970https://conductscience.org/library/papers/5452310PubMed
21128155A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.Life Sci1975https://conductscience.org/library/papers/1128155PubMed
3884021Vasodilator treatment for acute and chronic heart failure.Br Heart J1977https://conductscience.org/library/papers/884021PubMed
4203177Plasma norepinephrine in congestive heart failure.Am J Cardiol1978https://conductscience.org/library/papers/203177PubMed
5679493Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage.Clin Chim Acta1978https://conductscience.org/library/papers/679493PubMed
66766650Long-term therapy of heart failure with prazosin: a randomized double blind trial.Am J Cardiol1980https://conductscience.org/library/papers/6766650PubMed
7552299The two-period cross-over clinical trial.Br J Clin Pharmacol1979https://conductscience.org/library/papers/552299PubMed
87436166Increased plasma norepinephrine levels during prazosin therapy for severe congestive heart failure.Ann Intern Med1980https://conductscience.org/library/papers/7436166PubMed
96450219Determination of the vasodilator UK33274 by high-performance liquid chromatography using fluorescence detection.J Chromatogr1980https://conductscience.org/library/papers/6450219PubMed
107011023Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.Am J Med1981https://conductscience.org/library/papers/7011023PubMed
117223616Oral vasodilator therapy with prazosin in severe congestive heart failure.Am Heart J1981https://conductscience.org/library/papers/7223616PubMed
127246572Prazosin and congestive heart failure: short- and long-term therapy.Am J Med1981https://conductscience.org/library/papers/7246572PubMed
136266691Acute regional circulatory and renal hemodynamic effects of converting-enzyme inhibition in patients with congestive heart failure.Circulation1981https://conductscience.org/library/papers/6266691PubMed
147261282Results of long-term vasodilator therapy in patients with refractory congestive heart failure.Circulation1981https://conductscience.org/library/papers/7261282PubMed
157261283Determinants of drug response in severe chronic heart failure. 1. Activation of vasoconstrictor forces during vasodilator therapy.Circulation1981https://conductscience.org/library/papers/7261283PubMed
167264975The effect of intracerebroventricular injections of morphine on vasopressin release in the rat.J Physiol1981https://conductscience.org/library/papers/7264975PubMed
176115571Neurohumoral control mechanisms in congestive heart failure.Am Heart J1981https://conductscience.org/library/papers/6115571PubMed
186115578Clinical, hemodynamic, and neuroendocrine effects of chronic prazosin therapy for congestive heart failure.Am Heart J1981https://conductscience.org/library/papers/6115578PubMed
197053487Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure.N Engl J Med1982https://conductscience.org/library/papers/7053487PubMed
207317235Immediate and sustained haemodynamic effects of prazosin during upright exercise in man.Br Heart J1981https://conductscience.org/library/papers/7317235PubMed

See all 26 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
35894772Do adrenergic alpha-antagonists increase the risk of poor cardiovascular outcomes? A systematic review and meta-analysis.ESC Heart Fail2022https://conductscience.org/library/papers/35894772PubMed
22956185What will be the role of I-123 MIBG in improving the outcome of medically treated heart failure patients?J Nucl Cardiol2012https://conductscience.org/library/papers/22956185PubMed
21919922Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings.Alcohol Clin Exp Res2012https://conductscience.org/library/papers/21919922PubMed
3743613The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.Eur J Clin Pharmacol1986https://conductscience.org/library/papers/3743613PubMed
3569109The future role of inotropic drugs.Drugs1986https://conductscience.org/library/papers/3569109PubMed
3552590The role of vasodilator therapy in the treatment of severe chronic heart failure.Drugs1986https://conductscience.org/library/papers/3552590PubMed
3513808Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.Br Heart J1986https://conductscience.org/library/papers/3513808PubMed
3120955Mortality in congestive heart failure: effects of vasodilator therapy.Br Med J (Clin Res Ed)1987https://conductscience.org/library/papers/3120955PubMed
3075041The place of ACE inhibitors in the current treatment of chronic heart failure.Postgrad Med J1988https://conductscience.org/library/papers/3075041PubMed
3063499Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.Drugs1988https://conductscience.org/library/papers/3063499PubMed
3044507Flosequinan in heart failure: acute haemodynamic and longer term symptomatic effects.BMJ1988https://conductscience.org/library/papers/3044507PubMed
3044500Modern treatment of heart failure.BMJ1988https://conductscience.org/library/papers/3044500PubMed
3024949The treatment of heart failure. A methodological review of the literature.Drugs1986https://conductscience.org/library/papers/3024949PubMed
2841136A randomized cross-over study of enalapril in congestive heart failure: haemodynamic and hormonal effects during rest and exercise.Eur J Clin Pharmacol1988https://conductscience.org/library/papers/2841136PubMed
2653391Effect of flosequinan on exercise capacity and symptoms in severe heart failure.Br Heart J1989https://conductscience.org/library/papers/2653391PubMed
2598980Is addition of prazosin beneficial in chronic heart failure refractory to angiotensin converting enzyme inhibition?Eur J Clin Pharmacol1989https://conductscience.org/library/papers/2598980PubMed
2562137Low-dose enalapril in severe chronic heart failure.Cardiovasc Drugs Ther1989https://conductscience.org/library/papers/2562137PubMed
2049242'First dose' hypotension and venodilatation.Br J Clin Pharmacol1991https://conductscience.org/library/papers/2049242PubMed
2015167Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.Br J Clin Pharmacol1991https://conductscience.org/library/papers/2015167PubMed
1747275Vascular tone in heart failure: the neuroendocrine-therapeutic interface.Br Heart J1991https://conductscience.org/library/papers/1747275PubMed

See all 21 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3924285

GET https://conductscience.org/api/papers/v1/3924285/references?page=2